0
Deep & Emerging Tech·October 30, 2026·1 min read

Illumina CEO on Q3 Results and Business Outlook

Share

Illumina’s move from flat to mid-single-digit growth — with a target of high-single digits by 2027 — shows genomics is settling into an infrastructure role rather than a hype spike. If you build on sequencing data, plan for steady, not explosive, volume growth and focus on downstream analytics and workflows.